Why Insulet Is Dropping 6.7%: Barclays Maintains Underweight
[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence Insulet Corporation plunged 6.7% on Wednesday, closing at $147.69, after a wave of nine analyst downgrades and price target cuts slashed Wall Street’s outlook for the medical device maker by an average of…








